Marinel Lotrean et al. v. 3M Company et al.
Attorneys and Parties
Brief Summary
Toxic tort claims alleging that automotive solvents were contaminated with benzene, allegedly causing cancer.
The Supreme Court, New York County, denied summary judgment to E.I. du Pont/EIDP, Rust-Oleum, and Zep, allowing the claims to proceed.
The Appellate Division reversed, granted summary judgment to the defendants, and dismissed the complaint.
Defendants made a prima facie showing that the component solvents were not carcinogenic. Plaintiffs failed to present admissible evidence of general causation specific to benzene in the solvents at issue and failed to establish specific causation or dose, relying on unsupported assumptions of universal benzene contamination (0.1%) and non-comparable studies, contrary to Parker v Mobil Oil Corp., 7 NY3d 434 [2006], and Nemeth v Brenntag N. Am., 38 NY3d 336 [2022].
Background
Plaintiff Marinel Lotrean alleged cancer caused by exposure to solvent products used in his father's autobody shop. He sued multiple product manufacturers, including 3M, E.I. du Pont (now EIDP, Inc.), Rust-Oleum, and Zep, claiming the solvents were contaminated with benzene. Defendants argued the solvents' components are not carcinogenic and that plaintiffs lacked product-specific evidence of benzene contamination or exposure sufficient to cause disease.
Lower Court Decision
By order entered on or about April 29, 2024, the Supreme Court, New York County (Bannon, J.), denied the summary judgment motions of E.I. du Pont/EIDP, Rust-Oleum, and Zep.
Appellate Division Reversal
The Appellate Division, First Department unanimously reversed, granted the defendants' motions for summary judgment, and dismissed the complaint, directing the Clerk to enter judgment. The court held that plaintiffs failed to raise triable issues of fact on general causation (their experts focused on benzene generally rather than benzene in the specific solvent products and relied on a study with non-comparable exposure circumstances) and specific causation (exposure calculations assumed 0.1% benzene contamination in all solvents without evidentiary support), consistent with Parker and Nemeth.
Legal Significance
Reaffirms New York’s rigorous causation standards in toxic tort cases: plaintiffs must offer reliable, product-specific evidence that the toxin was present in the products used and in amounts sufficient to cause the alleged disease, along with scientifically sound dose assessments. General literature about a toxin’s hazards or assumptions about contamination are insufficient under Parker and Nemeth.
To survive summary judgment in solvent/benzene toxic tort cases, plaintiffs must prove actual benzene contamination in the defendants’ products and quantify exposure to a level capable of causing the illness; generalized benzene evidence and unsupported contamination assumptions will not suffice.